These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [How I treat....psoriasis comorbidities by adalimumab (Humira) anti-TNFalpha].
    Author: Piérard-Franchimont C, Henry F, Szepetiuk G, Piérard GE.
    Journal: Rev Med Liege; 2010 Oct; 65(10):545-8. PubMed ID: 21128358.
    Abstract:
    Psoriasis is primarily a chronic inflammatory skin disease burdened by some comorbidities including psoriatic alopecia, arthropathies, Crohn's disease, the metabolic syndrome and some cardiovascular involvement. During the past years, several biologicals corresponding to monoclonal antibodies were offered to treat psoriasis refractory to other potent conventional treatments. We review the effects of biologicals, in particular adalimumab (Humira), on psoriatic comorbidities.
    [Abstract] [Full Text] [Related] [New Search]